| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Carfilzomib, Free Base |
|---|
| Description | Carfilzomib, also known as PR-171, is an irreversible, epoxomicin-related proteasome inhibitor. Carfilzomib is a second-generation proteasome inhibitor that is being investigated as a potential treatment for patients with multiple myeloma and solid tumors. It is being studied in several clinical trials either as a single-agent or in combination with other therapies. MW: 719.91 g/mol. Purity >99% pure |
|---|
| Size | 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Kyprolis, PR-171, Carfilzomib (PR-171) |
|---|
| Gene, Accession, CAS # | CAS: 868540-17-4 |
|---|
| Catalog # | orb153608 |
|---|
| Price | |
|---|
| Order / More Info | Carfilzomib, Free Base from BIORBYT LTD. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|